医学
妊娠期糖尿病
优势比
横断面研究
四分位间距
家族史
糖尿病
产科
怀孕
置信区间
内科学
妊娠期
内分泌学
遗传学
病理
生物
作者
Kai Wei Lee,Siew Mooi Ching,Fan Kee Hoo,Vasudevan Ramachandran,Seng Choi Chong,Maiza Tusimin,Faith En Ang,Noraihan Mohd Nordin,Navin Kumar Devaraj
标识
DOI:10.1007/s11136-020-02532-3
摘要
This study aimed to identify factors associated with poor-to-moderate quality of life (QOL) among women with gestational diabetes mellitus (GDM) in two tertiary hospitals in Malaysia. A cross-sectional study was conducted among 526 pregnant women with GDM in two tertiary hospitals in Malaysia. Diabetes-related QOL was assessed using the Asian Diabetes Quality of Life Scale (AsianDQoL). Socio-demographic characteristics, glucose monitoring treatments for GDM, past obstetric history, concurrent medical problems and a family history of diseases were captured from patient records. A multiple logistic regression was used for analysis. A total of 526 respondents with GDM entered the analysis. The median age of the respondents was 32 (interquartile range = 7) while 82.3% were Malay women. More than half of the respondents (69.5%) received an oral hypoglycaemic agent (OHA), and/or diet modification in controlling their GDM. The study reported that 23.2% of the respondents had poor-to-moderate QOL. Those with a family history of depression and/or anxiety (adjusted Odds ratio [AOR] 6.934, 95% confidence interval [CI] 2.280–21.081), and a family history of GDM (AOR 1.814, 95% CI 1.185–2.778) were at higher odds of suffering from poor-to-moderate QOL compared to those without a family history. Similarly, those who received insulin, with or without OHA, and/or are on diet modification (AOR 1.955, 95% CI 1.243–3.074) were at higher odds of suffering from poor-to-moderate QOL compared to those receiving OHA and/or diet modification. Nearly one-quarter of Malaysian women with GDM have poor-to-moderate QOL. GDM women with a family history of depression and/or anxiety, family history of GDM, and those who received insulin, with or without OHA, and/or are on diet modification were associated with poor-to-moderate QOL. Trial registration: NMRR-17-2264-37814.
科研通智能强力驱动
Strongly Powered by AbleSci AI